of course they can do that

those are the targeted trades
between colluding entities

Finra themselves confirmed this
*activity* for me back in Feb 2010

that said .. i like to point (out) a few discrepancies
which can be corrected when noted

which is why when i caught factually false reporting
on another OTC *target* and brought it to Finra's attn
the data was corrected .. (it took a few weeks but was done)

it's also why i pointed out today's *efforts* and the inability
for my 8000 share sized bid @ 10c to be filled in total ..
rather it was nickeled and dimed today ..
in spite of NR actually generating IPIX volume maintenance (10 day)

again folks have to do what is best for themselves .. it's their money

i know exactly what has been done and why .. and as i keep pointing out
none of what has transpired against the company via its stock .. is unique

it's SOP on the OTC ..

but nothing beats an educated investor or an aware mgmt team *imo*

i would encourage every Innovation Pharma investor to file a complaint about
factually false *volume* reported in the legal .. imo there is a reason it has been done

last round was particularly *egregious* .. this round clearly not as much

4kids

A poster at iHub PMed me:

I'm not an expert on this, but, I've been told there are back deals between brokers and large clients that never hit the ticker tape so to speak. Could this account for the actual volume even though we don't see it in our brokerage accounts?

I'm going to have to research this since you are bringing up a good question.

The poster is good at digging up info so maybe a simple answer will come of it.

I don't have PM capability over there but thank you to the iHub poster if you read here at all.